Relationship of plasma anti-heparin activity and platelet survival time in coronary disease

Am Heart J. 1980 Apr;99(4):438-42. doi: 10.1016/0002-8703(80)90377-4.
No abstract available

MeSH terms

  • Aspirin / therapeutic use
  • Blood Coagulation Factors*
  • Blood Platelets / physiopathology*
  • Cell Survival / drug effects
  • Coronary Disease / blood*
  • Dipyridamole / therapeutic use
  • Double-Blind Method
  • Humans
  • Indomethacin / therapeutic use
  • Male
  • Platelet Factor 4*
  • Sulfinpyrazone / therapeutic use
  • Time Factors

Substances

  • Blood Coagulation Factors
  • Platelet Factor 4
  • Dipyridamole
  • Aspirin
  • Sulfinpyrazone
  • Indomethacin